Affordable Access

[Future developments in thrombolytic therapy].

Authors
Type
Published Article
Journal
Zeitschrift für Kardiologie
Publication Date
Volume
82 Suppl 2
Pages
187–190
Identifiers
PMID: 8328201
Source
Medline

Abstract

A primary failure rate to achieve reperfusion by thrombolytic therapy in acute myocardial infarction of 20-40%, an early reocclusion rate of 5-20%, as well as an increased risk of bleeding that excludes many patients from this form of therapy are today considered main problems. Better application of conventional thrombolytic agents, new conjunctive therapies and development of improved plasminogen activators are investigated with the aim of minimizing these problems.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F